Antipsychotics
14 drugs in this class, prescribed by 216,716 Medicare Part D providers.
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$2.43B
Total Cost
10,068,042
Claims
14
Drugs
$241
Avg Cost/Claim
Key Insights
- Most expensive per prescription: Invega Sustenna at $3,298/claim
- Most prescribed: Quetiapine Fumarate with 3,820,737 claims
- This class represents 0.9% of total Medicare Part D spending
All Antipsychotics Drugs
| Drug | Cost | Claims |
|---|---|---|
| Paliperidone Palmitate | $832.3M | 252,388 |
| Aripiprazole | $373.1M | 1,494,971 |
| Cariprazine Hcl | $329.1M | 226,854 |
| Brexpiprazole | $204.0M | 136,378 |
| Lurasidone Hcl | $190.9M | 254,237 |
| Quetiapine Fumarate | $100.9M | 3,820,737 |
| Aripiprazole Lauroxil | $93.3M | 31,120 |
| Risperidone Microspheres | $64.8M | 47,567 |
| Olanzapine | $59.4M | 1,444,781 |
| Paliperidone | $49.3M | 129,516 |
| Clozapine | $47.0M | 491,951 |
| Risperidone | $37.4M | 1,480,207 |
| Olanzapine/Samidorphan Malate | $28.3M | 18,294 |
| Ziprasidone Hcl | $20.8M | 239,041 |